{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:49:37Z","timestamp":1648745377168},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11657-017-0350-3","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T05:15:35Z","timestamp":1500268535000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of gastrointestinal events on patient-reported outcomes in Asia-Pacific women with osteoporosis: baseline results of the MUSIC OS-AP study"],"prefix":"10.1007","volume":"12","author":[{"given":"A.","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. K.","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mithal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sajjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"350_CR1","unstructured":"Mithal A, Dhingra V, Lau E (2009) The Asian Audit- Epidemiology, costs and burden of osteoporosis in Asia 2009: A report of International Osteoporosis Foundation 2009. \nhttps:\/\/www.iofbonehealth.org\/sites\/default\/files\/PDFs\/Audit%20Asia\/Asian_regional_audit_2009.pdf\n\n. Accesssed 15 Feb 2015"},{"key":"350_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11657-014-0182-3","volume":"9","author":"SW Wade","year":"2014","unstructured":"Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O\u2019Malley CD (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182. doi:\n10.1007\/s11657-014-0182-3","journal-title":"Arch Osteoporos"},{"key":"350_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9343(03)00362-0","volume":"115","author":"AN Tosteson","year":"2003","unstructured":"Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209\u2013216","journal-title":"Am J Med"},{"key":"350_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00296-009-0940-5","volume":"30","author":"JD Ringe","year":"2009","unstructured":"Ringe JD, Moller G (2009) Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. Rheumatol Int 30:213\u2013221. doi:\n10.1007\/s00296-009-0940-5","journal-title":"Rheumatol Int"},{"key":"350_CR5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/147323000903700430","volume":"37","author":"J Payer","year":"2009","unstructured":"Payer J, Cierny D, Killinger Z, Sulkova I, Behuliak M, Celec P (2009) Preferences of patients with post-menopausal osteoporosis treated with bisphosphonates\u2014the VIVA II study. J Int Med Res 37:1225\u20131229","journal-title":"J Int Med Res"},{"key":"350_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s00198-006-0085-2","volume":"17","author":"JC Lo","year":"2006","unstructured":"Lo JC, Pressman AR, Omar MA, Ettinger B (2006) Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int 17:922\u2013928. doi:\n10.1007\/s00198-006-0085-2","journal-title":"Osteoporos Int"},{"key":"350_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s00198-006-0073-6","volume":"17","author":"M Rossini","year":"2006","unstructured":"Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914\u2013921. doi:\n10.1007\/s00198-006-0073-6","journal-title":"Osteoporos Int"},{"key":"350_CR8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1185\/030079908X297358","volume":"24","author":"FJ Penning-van Beest","year":"2008","unstructured":"Penning-van Beest FJ, Erkens JA, Olson M, Herings RM (2008) Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis. Curr Med Res Opin 24:1337\u20131344. doi:\n10.1185\/030079908X297358","journal-title":"Curr Med Res Opin"},{"key":"350_CR9","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1359\/jbmr.080510","volume":"23","author":"AM Gallagher","year":"2008","unstructured":"Gallagher AM, Rietbrock S, Olson M, van Staa TP (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 23:1569\u20131575. doi:\n10.1359\/jbmr.080510","journal-title":"J Bone Miner Res"},{"key":"350_CR10","doi-asserted-by":"publisher","unstructured":"Modi A, Siris S, Yang X, Fan CP, Sajjan S (2015) Association between gastrointestinal events and persistence with osteoporosis therapy: analysis of administrative claims of a U.S. managed care population. J Manag Care Spec Pharm 21:499\u2013506. doi:\n10.18553\/jmcp.2015.21.6.499","DOI":"10.18553\/jmcp.2015.21.6.499"},{"key":"350_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2474-15-112","volume":"15","author":"H Yun","year":"2014","unstructured":"Yun H, Curtis JR, Guo L, Kilgore M, Muntner P, Saag K, Matthews R, Morrisey M, Wright NC, Becker DJ, Delzell E (2014) Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries. BMC Musculoskelet Disord 15:112. doi:\n10.1186\/1471-2474-15-112","journal-title":"BMC Musculoskelet Disord"},{"key":"350_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/SMJ.0b013e31819ed0dd","volume":"102","author":"N Binkley","year":"2009","unstructured":"Binkley N, Martens MG, Silverman SL, Derman RJ, Greenwald M, Kohles JD, Bachmann GA (2009) Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates. South Med J 102:486\u2013492. doi:\n10.1097\/SMJ.0b013e31819ed0dd","journal-title":"South Med J"},{"key":"350_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1185\/03007991003633603","volume":"26","author":"C Woo","year":"2010","unstructured":"Woo C, Gao G, Wade S, Hochberg MC (2010) Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study. Curr Med Res Opin 26:1003\u20131009. doi:\n10.1185\/03007991003633603","journal-title":"Curr Med Res Opin"},{"key":"350_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0149-2918(04)90023-9","volume":"26","author":"C Turbi","year":"2004","unstructured":"Turbi C, Herrero-Beaumont G, Acebes JC, Torrijos A, Grana J, Miguelez R, Sacristan J, Marin F (2004) Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clin Ther 26:245\u2013256","journal-title":"Clin Ther"},{"key":"350_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1345\/aph.1L555","volume":"43","author":"WA Blumentals","year":"2009","unstructured":"Blumentals WA, Harris ST, Cole RE, Huang L, Silverman SL (2009) Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate. Ann Pharmacother 43:577\u2013585. doi:\n10.1345\/aph.1L555","journal-title":"Ann Pharmacother"},{"key":"350_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00223-011-9511-3","volume":"89","author":"E Landfeldt","year":"2011","unstructured":"Landfeldt E, Lang A, Robbins S, Strom O (2011) Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish adherence register analysis (SARA). Calcif Tissue Int 89:234\u2013245. doi:\n10.1007\/s00223-011-9511-3","journal-title":"Calcif Tissue Int"},{"key":"350_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bonr.2015.09.002","volume":"3","author":"A Modi","year":"2015","unstructured":"Modi A, Ebeling P, Lee MS, Min YK, Mithal A, Yang X, Sajjan S (2015) Medication use patterns, treatment satisfaction, and inadequate control of osteoporosis study in the Asia-Pacific region (MUSIC OS-AP): design of a multinational, prospective, observational study examining the impact of gastrointestinal events on osteoporosis management in postmenopausal women. Bone Rep 3:61\u201366. doi:\n10.1016\/j.bonr.2015.09.002","journal-title":"Bone Rep"},{"key":"350_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00198-011-1555-8","volume":"23","author":"V Breuil","year":"2012","unstructured":"Breuil V, Cortet B, Cotte FE, Arnould B, Dias-Barbosa C, Gaudin AF, Regnault A, Roborel de Climens A, Legrand E (2012) Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporos Int 23:445\u2013455. doi:\n10.1007\/s00198-011-1555-8","journal-title":"Osteoporos Int"},{"key":"350_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1477-7525-4-42","volume":"4","author":"EM Flood","year":"2006","unstructured":"Flood EM, Beusterien KM, Green H, Shikiar R, Baran RW, Amonkar MM, Cella D (2006) Psychometric evaluation of the osteoporosis patient treatment satisfaction questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women. Health Qual Life Outcomes 4:42. doi:\n10.1186\/1477-7525-4-42","journal-title":"Health Qual Life Outcomes"},{"key":"350_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol group. Ann Med 33:337\u2013343","journal-title":"Ann Med"},{"key":"350_CR21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","volume":"14","author":"SJ Walters","year":"2005","unstructured":"Walters SJ, Brazier JE (2005) Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14:1523\u20131532","journal-title":"Qual Life Res"},{"key":"350_CR22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.mlr.0000172050.67085.4f","volume":"43","author":"PW Sullivan","year":"2005","unstructured":"Sullivan PW, Lawrence WF, Ghushchyan V (2005) A national catalog of preference-based scores for chronic conditions in the United States. Med Care 43:736\u2013749","journal-title":"Med Care"},{"key":"350_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1023\/A:1008934208764","volume":"9","author":"S Silverman","year":"2000","unstructured":"Silverman S (2000) The osteoporosis assessment questionnaire (OPAQ): a reliable and valid disease-targeted measure of health-related quality of life (HRQOL) in osteoporosis. Qual Life Res 9:767\u2013774. doi:\n10.1023\/A:1008934208764","journal-title":"Qual Life Res"},{"key":"350_CR24","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00198-014-2695-4","volume":"25","author":"A Nixon","year":"2014","unstructured":"Nixon A, Kerr C, Doll H, Naegeli AN, Shingler SL, Breheny K, Burge R, Gold DT, Silverman S (2014) Osteoporosis assessment questionnaire-physical function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function. Osteoporos Int 25:1775\u20131784. doi:\n10.1007\/s00198-014-2695-4","journal-title":"Osteoporos Int"},{"key":"350_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00774-007-0768-6","volume":"25","author":"M Kamatari","year":"2007","unstructured":"Kamatari M, Koto S, Ozawa N, Urao C, Suzuki Y, Akasaka E, Yanagimoto K, Sakota K (2007) Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Miner Metab 25:302\u2013309. doi:\n10.1007\/s00774-007-0768-6","journal-title":"J Bone Miner Metab"},{"key":"350_CR26","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00198-008-0618-y","volume":"19","author":"H Ideguchi","year":"2008","unstructured":"Ideguchi H, Ohno S, Takase K, Ueda A, Ishigatsubo Y (2008) Outcomes after switching from one bisphosphonate to another in 146 patients at a single university hospital. Osteoporos Int 19:1777\u20131783. doi:\n10.1007\/s00198-008-0618-y","journal-title":"Osteoporos Int"},{"key":"350_CR27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00198-015-3388-3","volume":"27","author":"A Modi","year":"2016","unstructured":"Modi A, Sen S, Adachi JD, Adami S, Cortet B, Cooper AL, Geusens P, Mellstrom D, Weaver J, van den Bergh JP, Nguyen AM, Sajjan S, Group M-OS (2016) Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study. Osteoporos Int 27:1227\u20131238. doi:\n10.1007\/s00198-015-3388-3","journal-title":"Osteoporos Int"},{"key":"350_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00774-011-0326-0","volume":"30","author":"KW Oh","year":"2012","unstructured":"Oh KW, Kim DY, Lee YS, Kang MI (2012) Osteoporosis patient treatment satisfaction questionnaire in postmenopausal women intermittently treated with oral bisphosphonates: the BRAVO study. J Bone Miner Metab 30:359\u2013366. doi:\n10.1007\/s00774-011-0326-0","journal-title":"J Bone Miner Metab"},{"key":"350_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00223-009-9294-y","volume":"85","author":"YS Chung","year":"2009","unstructured":"Chung YS, Lim SK, Chung HY, Lee IK, Park IH, Kim GS, Min YK, Kang MI, Chung DJ, Kim YK, Choi WH, Shong MH, Park JH, Byun DW, Yoon HK, Shin CS, Lee YS, Kwon NH (2009) Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women. Calcif Tissue Int 85:389\u2013397. doi:\n10.1007\/s00223-009-9294-y","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 3","key":"350_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.16.S3.1","volume":"16","author":"NB Watts","year":"2010","unstructured":"Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM (2010) American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 16(Suppl 3):1\u201337","journal-title":"Endocr Pract"},{"key":"350_CR31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","volume":"148","author":"C MacLean","year":"2008","unstructured":"MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M, Desai SB, Zhou A, Chen S, Carter J, Tringale C, Valentine D, Johnsen B, Grossman J (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:197\u2013213","journal-title":"Ann Intern Med"},{"key":"350_CR32","volume-title":"Assessment of osteoporosis at the primary health-care level. World Health Organization Collaborating Centre for metabolic bone diseases","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, On behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary health-care level. World Health Organization Collaborating Centre for metabolic bone diseases. University of Sheffield, United Kingdom"},{"key":"350_CR33","first-page":"594","volume":"21","author":"FY Chang","year":"2012","unstructured":"Chang FY, Chen PH, Wu TC, Pan WH, Chang HY, Wu SJ, Yeh NH, Tang RB, Wu L, James FE (2012) Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria. Asia Pac J Clin Nutr 21:594\u2013600","journal-title":"Asia Pac J Clin Nutr"},{"key":"350_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1751-2980.2007.00304.x","volume":"8","author":"KL Goh","year":"2007","unstructured":"Goh KL (2007) Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis 8:179\u2013185. doi:\n10.1111\/j.1751-2980.2007.00304.x","journal-title":"J Dig Dis"},{"key":"350_CR35","unstructured":"Guarner F, L\u00e1zaro, Gasc\u00f3n, Royo, Eximan, Herrero (2008) Map of digestive disorders & diseases. World Gastroenterology Organisation. \nhttp:\/\/www.worldgastroenterology.org\/assets\/downloads\/pdf\/wdhd\/2008\/events\/map_of_digestive_disorders_2008.pdf\n\n. Accessed 25 Feb 2015"},{"key":"350_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5056\/jnm.2011.17.3.235","volume":"17","author":"UC Ghoshal","year":"2011","unstructured":"Ghoshal UC, Singh R, Chang FY, Hou X, Wong BC, Kachintorn U, Functional Dyspepsia Consensus Team of the Asian N, Motility A, the Asian Pacific Association of G (2011) Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil 17:235\u2013244. doi:\n10.5056\/jnm.2011.17.3.235","journal-title":"J Neurogastroenterol Motil"},{"key":"350_CR37","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s11136-014-0676-x","volume":"23","author":"S Clemens","year":"2014","unstructured":"Clemens S, Begum N, Harper C, Whitty JA, Scuffham PA (2014) A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Qual Life Res 23:2375\u20132381. doi:\n10.1007\/s11136-014-0676-x","journal-title":"Qual Life Res"},{"key":"350_CR38","unstructured":"Self-Reported Population Health: an international perspective based on EQ-5D (2014). 1 edn. Springer: Netherlands"},{"key":"350_CR39","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s11136-015-0978-7","volume":"24","author":"ST Yu","year":"2015","unstructured":"Yu ST, Chang HY, Yao KP, Lin YH, Hurng BS (2015) Validity of EQ-5D in general population of Taiwan: results of the 2009 National Health Interview and drug abuse survey of Taiwan. Qual Life Res 24:2541\u20132548. doi:\n10.1007\/s11136-015-0978-7","journal-title":"Qual Life Res"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-017-0350-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-017-0350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-017-0350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:16:35Z","timestamp":1515449795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-017-0350-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1007\/s11657-017-0350-3","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,17]]},"article-number":"65"}}